When is targeted therapy recommended for neuroendocrine tumours?

A target on testing does not by itself mean treatment is needed. The expected benefit, other options, kidney or liver function, interactions with current medicines and your preferences all matter. A multidisciplinary team may review the pathology and imaging before recommending a plan.

Ask whether the pathology report includes the tumour grade, origin and relevant receptor or molecular results. Bring details of medicines, supplements, diabetes or blood-pressure treatment and any hormone-related symptoms such as flushing, wheezing or persistent diarrhoea. Discuss how treatment is taken, how scans and blood tests will be used, and which side effects need prompt advice. Keep a record of symptoms and do not alter doses without speaking with the treating team.

Get urgent help for severe breathlessness, chest pain, fainting, confusion, sudden weakness, heavy bleeding or severe dehydration. Contact your treatment team promptly for persistent vomiting or diarrhoea, yellowing of the skin, very little urine, a high fever, rapidly worsening flushing or wheezing, or symptoms that are becoming difficult to control.

What feature of my tumour makes targeted therapy an option? Is the treatment intended to control growth, hormone symptoms or both? What tests confirm the target? Which alternatives fit my tumour and priorities? How will we know whether the treatment is helping?